Position in RNTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$762,464
+$314,368 QoQ
Shares Held
733,139
+112.7% QoQ
Ownership
0.850%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 59 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. RNTX ranks #333 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in RNTX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $762,464 | 733,139 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $448,096 | 344,690 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $330,083 | 284,555 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $283,170 | 247,311 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $343,636 | 245,455 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $435,588 | 246,096 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $555,304 | 241,437 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $813,551 | 229,817 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $472,137 | 170,447 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $462,502 | 69,759 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $174,671 | 57,288 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $85,899 | 56,513 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $98,532 | 55,046 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $67,950 | 54,799 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $105,436 | 44,488 | Shares | Defined | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||